Related Experiment Videos
Spermatocytic seminoma: a review.
Peter W M Chung1, Andrew J S Bayley, Joan Sweet
1Department of Radiation Oncology, Princess Margaret Hospital, 610, University of Toronto, Toronto, Ontario, Canada M5G 2M9.
European Urology
|March 26, 2004
Summary
Spermatocytic seminoma, a rare testicular cancer, rarely metastasizes. Surveillance after surgery is the preferred management, showing no relapses in a recent study.
Area of Science:
- Oncology
- Urology
- Pathology
Background:
- Spermatocytic seminoma is a rare testicular neoplasm with a very low metastatic potential.
- This tumor is typically observed in older men, but recent findings suggest it can occur in younger individuals.
Purpose of the Study:
- To review the management of spermatocytic seminoma at a single institution.
- To evaluate the outcomes of different treatment strategies for this rare tumor.
Main Methods:
- Retrospective review of 13 patients diagnosed with spermatocytic seminoma between 1981 and 1999.
- Patients were managed with either radiotherapy or surveillance after orchidectomy.
- Pathology was reviewed locally prior to treatment.
Main Results:
- All 13 patients had stage I disease.
- No relapses were observed in patients undergoing surveillance (n=7) or radiotherapy (n=5) with a median follow-up of 8.5 years.
- Adverse histological features like rete testis invasion were noted in some patients.
Conclusions:
- Spermatocytic seminoma can affect younger patients, challenging the notion of it being exclusively a disease of the elderly.
- Active surveillance following orchidectomy appears to be a safe and effective management strategy for stage I spermatocytic seminoma.